Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Epilepsy study sheds light on survival chances
Italian spinone
Researchers found affected dogs with no cluster seizures lived significantly longer.
Research uncovers prevalence of IE in Italian Spinoni

Idiopathic epilepsy is more prevalent in Italian Spinoni that the general canine population, according to research by the Animal Health Trust (AHT). Their study, believed to be the first of its kind, may help to improve survival in these dogs.

Over 5 per cent of the Italian Spinoni involved in the research were found to have the condition. In the UK's general canine population, prevalence is estimated to be just 0.6 per cent, though it can be as high as 18.3 per cent, depending on country and breed.

In the AHT's survey of 1,192 Spinone owners, 63 dogs had idiopathic epilepsy (IE). The owners of these dogs were then invited to complete a further questionnaire and make available their dog's medical records.

Looking at the survival times of the affected dogs, researchers found those with no cluster seizures lived significantly longer. Survival was also substantially longer in Italian Spinoni whose treatment with anti-epileptic medication had started after the second seizure, rather than after the third.

Lead author Luisa De Risio explained: "From this sample we were able to conclude that idiopathic epilepsy in this breed often has a severe presentation but starting treatment with antiepileptic medication after the second seizure, and aggressive treatment of cluster seizures, may improve the survival of these dogs."

IE is the most common, chronic neurological disorder seen in dogs, but appears more commonly in some breeds than others, including Irish wolfhounds, border collies and of course, Italian Spinoni. It is a very complex and difficult disease to treat in dogs, just as it is in humans.

Work is also underway at AHT to identify the genetic mutations responsible for the disease so a genetic test could be developed. Due to the complexity of the genetics, however, such a test is most likely "many years away", Dr De Risio says.

In the meantime, she adds: "We hope these findings will help to increase veterinary knowledge and understanding of this horrible disease and give Italian Spinoni, and other affected breeds, the best chance of fighting IE."

Become a member or log in to add this story to your CPD history

RUMA CA&E extends survey deadline

News Story 1
 RUMA CA&E has extended the deadline for its online survey into vaccine availability.

Vets, SQPs, retailers and wholesalers will now have until Friday, 26 September at 5pm to submit their response.

The survey aims to further understanding into the vaccine supply challenges faced by the sector. It will also consider the short and long term impacts of disruption issues.

Insights are anonymous, and will be shared with industry stakeholders and government bodies.

The survey can be accessed here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com